Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in mice
Global containment of COVID-19 still requires accessible and affordable vaccines for low- and middle-income countries (LMICs). Recently approved vaccines provide needed interventions, albeit at prices that may limit their global access. Subunit vaccines based on recombinant proteins are suited for l...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Other Authors: | , , , , |
Format: | Article |
Language: | English |
Published: |
National Academy of Sciences,
2021-10-04T16:04:00Z.
|
Subjects: | |
Online Access: | Get fulltext |